PET imaging with FAPI-ligands for non-cirrhotic hepatocellular carcinoma-Reference-Cited by-同舟云学术

PET imaging with FAPI-ligands for non-cirrhotic hepatocellular carcinoma

Published:2023-07-05 Issue:11 Volume:50 Page:3190-3191
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Lee Zhenghong^ORCID,Lu Zheng-Rong,Sexton Sandra,Xin Wei

Funder

National Institutes of Health

U.S. Department of Defense

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00259-023-06324-y.pdf

Reference11 articles.

1. Zhou Y, et al. [(68) Ga]Ga-DOTA-FAPI-04 PET/CT imaging of cirrhosis with hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2023;50(5):1536–7. https://doi.org/10.1007/s00259-022-06077-0.

2. Desai A, Sandhu S, Lai JP, Sandhu DS. Hepatocellular carcinoma in non-cirrhotic liver: a comprehensive review. World J Hepatol. 2019;11(1):1–18. https://doi.org/10.4254/wjh.v11.i1.1.

3. Yen YH, Cheng YF, Wang JH, Lin CC, Wang CC. Characteristics and etiologies of hepatocellular carcinoma in patients without cirrhosis: when East meets West. PloS One. 2021;16(1):e0244939. https://doi.org/10.1371/journal.pone.0244939.

4. Gerin JL, Cote PJ, Korba BE, Tennant BC. Hepadnavirus-induced liver cancer in woodchucks. Cancer Detect Prev. 1989;14(2): 227–9. Available: http://www.ncbi.nlm.nih.gov/pubmed/2695243.

5. Aravalli RN, Steer CJ. “Animal models of liver cancer,” in Hepatocellular carcinoma: cellular and molecular mechanisms and novel therapeutic strategies. Cham: Springer International Publishing; 2014. p. 47–50.